Grail Blood Test Detects Over 50 Cancers, Significantly Outperforming Standard Tests
Grail's Galleri blood test detected seven times more cancers than standard methods in a large study, with over half being early-stage and in hard-to-screen areas, showing promising accuracy and potential for routine screening pending FDA approval.